Maybe one day Dr Dalton will recommend something good to

New Post Public Reply Private Reply Replies (2) Message Board
mikeyt1818 jrt03 #5506
360
Maybe one day Dr Dalton will recommend something good to replace my Klonopin? Cannabis might not be a cure-all but it does cure much!

Get to know Dr David Dalton, a man of vision and integrity:

Dr. David Dalton is Chairman, President and CEO of Univec Inc. and subsidiary Physician and Pharmaceutical Services Inc. (PPSI). Dr. David Dalton has spent his professional career in the pharmaceutical industry, bringing 45 years of experience to his profession. He received a B.S. in pharmacy from West Virginia in 1971 and was honored as one of the top ten graduates over a 100 - year span. Dr.Dalton became a Doctor of Pharmacy in 1974. He served in several capacities with Rite Aid Corporation from 1971 to 1989 including Corporate Vice President. He left Rite Aid Corporation to acquire Peoples Drug Stores with an investment Group inclusive of Robert Bass of Texas. Dr. Dalton served as Senior Vice President.

Dr. Dalton then acquired Sherman Management Group, one of the first worker compensation pharmacy benefit management companies in the United States and Medical Service Agency, where he served as Chairman, President, and CEO, which he merged in November of 1994 to
MEDNET, a national Pharmacy Benefit Management Company (PBM) listed on NASDAQ.

Dr. Dalton served as Executive Vice President of MEDNET and President of Medi-Claim (a wholly owned subsidiary of MEDNET). Dr. Dalton’s next venture, Managed Care Rx, a National Specialty care pharmaceutical provider for assisted living facilities, nursing homes, and prisons, was merged with, a subsidiary of Bergen Brunswick, a drug wholesale company with sales in excess of $14 billion.


His next venture, Health Resources, Inc. for which he is Founder, President and CEO is a national pharmacy benefit management company that has contracted with over 70,000 retail pharmacies for the fulfillment of prescription orders and Pharmacy Services, Inc. a nationwide prescription mail service company. HRI had a revenue of $182 million in 2017.


Dr. Dalton is one of the original members and directors of the National Council of Prescription Drug Programs (NCPDP) and responsible for the standards that pharmacies use across the United States to transmit prescriptions.

Dr. Dalton has served as a board member on such organizations as Blue Shield of Pennsylvania, United Way, National Health Association, National Association of Chain Drug Stores, (NACDS) .

He has been a visiting professor and lectures at several schools of pharmacy throughout the United States and Past President of West Virginia University School of Pharmacy Presidential Committee. Dr. Dalton has received national and local recognition by the President and Senate of the United States including the Medal of Freedom the highest honor given by the United States Senate. In addition the University of West Virginia recognized him as a Distinguished Alumni and again honored him as Outstanding Alumni of West Virginia School of Pharmacy and Outstanding Service recognition to the School of Pharmacy of West Virginia University. Dr.Dalton was inducted into the Black CEO Hall of Fame in 2006.

Univec Conglomerate Inc (UNVC) Stock Research Links

UNVC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 121

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 228

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 138

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 206

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 201

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 136

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 531

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 110

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading

Top 5 Most Recently Viewed Articles

Massive Trading Activity Spotted in Tempus AI (TEM) Options

Updated Category News Views 292

Unprecedented Trading Interest in Tempus AI Options Investors with significant capital are showing a strong bullish outlook on Tempus AI (TEM). This surge in trading activity is something every retail trader should pay attention to. Identifying Smart Money Moves Today, we observed notable trends in the options market for Tempus AI, highlighting the actions of big-money...

Continue Reading
Endeavour Mining Sees Significant Stake Notification from BlackRock

Updated Category News Views 143

Endeavour Mining and Major Shareholding Update Endeavour Mining plc is making headlines with its latest update regarding shareholders. Recently, the company received a notable notification from BlackRock, Inc., one of the world’s leading investment management firms. This announcement highlights BlackRock's interests in Endeavour Mining, showcasing the ongoing...

Continue Reading
Adverity Unveils Innovative Data Quality Suite for Clients

Updated Category News Views 188

Adverity launched its Data Quality Suite a while back, promising to revolutionize how businesses tackle data management. But let’s dig deeper—what’s the real deal here? Data Quality: A Marketing Essential or Just Noise? In this digital mess we call life, clean data isn’t just a luxury; it’s an absolute necessity. Back then, marketing and analytics teams faced a...

Continue Reading
Strengthening Medical Connections Between U.S. and Jordan

Updated Category News Views 225

Strengthening Medical Collaborations Dr. Maen Hussein, a talented medical oncologist and hematologist, recently held an important meeting with King Abdullah II of Jordan. This gathering aimed to enhance the collaboration between medical professionals in both the United States and Jordan, showcasing the commitment to elevate healthcare standards through shared knowledge...

Continue Reading
Alphabet's Stock Outlook Amid DOJ Challenges: Key Insights

Updated Category News Views 101

Alphabet's Price Target Change: Implications Recently, Evercore ISI adjusted its price target for Alphabet Inc. (NASDAQ: GOOGL), reducing it from $225 to $200. Even with this decrease, Evercore retains an Outperform rating for the stock. This change signals growing concerns over the ongoing antitrust trials led by the Department of Justice (DOJ), which could heavily...

Continue Reading